Protecting gamers' eyes with lubricating eyedrops

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the protective effect of TheaLoz Duo lubricating eyedrops on the ocular surface of handheld console and computer gamers suffering from dry eye symptoms. Participants will be randomly assigned to receive either the eyedrop treatment or a control condition over two months, with assessments conducted at the Aston Dry Eye Clinic. The study aims to determine if these eyedrops can alleviate symptoms of dry eye disease caused by prolonged screen use.

Why it matters

Who can join: the full rules

Inclusion criteria:

* Individuals with dryness symptoms as assessed with the Ocular Surface Disease Index (OSDI score ≥ 13).
* Individuals who play handheld console and computer-based games ≥ 2 hours everyday on average
* Individuals who are comfortable and competent at using smartphone applications
* Age ≥ 18 years, male or female
* Able to provide written consent in English
* Able to instil the treatment lubricating eyedrop on their own, and return any provided eyedrop bottle to the researcher used at the end of the treatment
* Able to attend multiple visits (3 visits over 2 months)

Exclusion criteria:

* Pregnancy
* Use of any topical ocular medical eyedrops or lubricants in the 1 week prior to starting the study or during the study period. Those who are using existing lubricating eyedrops and are interested in participating will be required to stop their lubricating eyedrops for 1 week prior to commencing the study
* History of ocular surgery, trauma or infections in the past 6 months

Where it's running

• School of Optometry, Aston University
  Birmingham, West Midlands, United Kingdom Recruiting

Study contacts

• Study coordinator: James S Wolffsohn, PhD
• Email: dryeye@aston.ac.uk
• Phone: +441212044400

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Lycium barbarum polysaccharide for dry eye symptoms in adults

  Adults with dry eye disease will try taking Lycium barbarum polysaccharide tablets twice daily for 12 weeks to see if their symptoms and eye tests improve and to check safety.

  Recruiting The Hong Kong Polytechnic University · Hong Kong, Hong Kong · NCT07842536

• See if rinsing the eye reduces inflammation and symptoms in severe dry eye

  This trial tests whether rinsing the surface of the eye can lower inflammation and improve symptoms for people with severe dry eye disease.

  Recruiting Rinsada · Pittsburgh, Pennsylvania · NCT07618364

• Eye drops combining an added medicinal ingredient with hyaluronic acid 0.3% versus hyaluronic acid 0.3% alone for moderate-to-severe dry eye

  We will test whether eye drops that combine an additional medicinal ingredient with hyaluronic acid 0.3% help adults with moderate-to-severe dry eye as well as or better than hyaluronic acid 0.3% alone.

  Recruiting at 2 sites FB Vision S.p.A · Cagliari, CA and 1 other locations · NCT07412860

• Comparing tear structure in menopausal and non-menopausal women

  This study is testing how menopause affects tear quality and production in women, including those on hormone therapy, to see if there are differences between pre-menopausal and post-menopausal women.

  Recruiting Chung Shan Medical University · Taichung, Taiwan · NCT06848829

• Using Platelet-Rich Plasma to Treat Severe Dry Eye Syndrome

  This study is testing if injecting Platelet-Rich Plasma into the tear glands can help people with severe dry eye syndrome produce more tears and feel better.

  Recruiting Centre Hospitalier Universitaire de Nice · Nice, Site Principal Investigator · NCT06831253

• Comparing red and blue light therapy for dry eye conditions

  This study is testing whether red or blue light therapy can help people with dry eye conditions feel better and improve their eye health.

  Recruiting Aston University · Auckland and 1 other locations · NCT06371300

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.